Cardiovascular disease (CVD) is a group of diseases that include both the heart and blood vessels, thereby including coronary heart disease (CHD) and coronary artery disease (CAD), and acute coronary syndrome (ACS) among several other conditions. According to the Centers for Disease Control and Prevention (CDC), coronary heart disease accounts for 610,000 deaths in the U.S. each year. CHD is a major cause of death and disability in developed countries. The global diagnostic interventional cardiology devices market is primarily driven by rising prevalence of coronary artery diseases such as acute myocardial infarction and angina pectoris, increasing burden of cardiovascular diseases and the growing elderly population. Several other medical conditions and lifestyle choices can also put people at a higher risk for heart disease, including: diabetes, overweight and obesity, poor diet, physical inactivity, and excessive alcohol use.
The global diagnostic interventional cardiology devices market segmentation is based on device type (transcatheter angiography devices, intravascular ultrasound (IVUS) devices, guide wire-based intravascular stenosis assessment or fractional flow reserve (FFR) devices, intracardiac echocardiography (ICE) devices, optical coherence tomography (OCT) devices, and robotic-assisted surgical devices).
The global diagnostic interventional cardiology devices market research report provides market size (Revenue US$ Million 2014 to 2021), market share analysis, growth trends and forecast (CAGR%, 2017 to 2021). The global diagnostic interventional cardiology devices market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. In addition, the global diagnostic interventional cardiology devices market report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.
Major players operating in the global diagnostic interventional cardiology devices market and profiled in this report include ACIST Medical Systems (Bracco SPA), Auris Surgical Robotics Inc., B. Braun Medical (B. Braun Melsungen), Biosense Webster Inc. (Johnson & Johnson), Boston Scientific Corp., Catheter Precision, Cook Medical, Corindus Vascular Robotics Inc., GE Healthcare, Hansen Medical Inc., Kaiser Permanente, Medtronic PLC, Merit Medical Systems, Opsens Inc., Philips Healthcare/ Royal Phillips, Siemens Healthineers, St. Jude Medical Inc. (Abbott International), Stereotaxis Inc., Shimadzu Medical Systems, Smiths Medical, Terumo Interventional, and Toshiba America Medical Systems.